By Jim Schutze
By Rachel Watts
By Lauren Drewes Daniels
By Anna Merlan
By Lee Escobedo
By Eric Nicholson
Still, CSPI has raised important issues and consumer awareness about a product expected to be widely distributed in the food supply. Its charge that olestra removes certain nutrients from the body is borne out by studies. P&G was forced to fortify olestra with vitamins A, D, E, and K to ensure FDA approval. In addition, its assertion that olestra impairs the body's ability to absorb carotenoids, substances found in certain vegetables that may lower cancer risk, is supported by Harvard School of Public Health Chair Walter Willett.
But, the FDA counters, there is currently not a single study demonstrating that carotenoids prevent cancer, and even CSPI admits the verdict on any salutary benefits of carotenoids is far from conclusive. "There is not a lot of support in the scientific community right now for carotenoids," says CSPI's Miller. "But there is evidence growing that they can prevent cancer."
As Jeff Stier of ACSH says, the issue is not that olestra might pose certain minimal consumer health risks, but that consumers should be allowed to consider those alleged risks when making purchasing decisions. If CSPI has its way in its drive to revoke FDA approval of olestra, the opportunity for informed consumer choice would be eliminated.
Find everything you're looking for in your city
Find the best happy hour deals in your city
Get today's exclusive deals at savings of anywhere from 50-90%
Check out the hottest list of places and things to do around your city